Delivery Order SPE2DB20D2014-SPE2DB25FA56D

Award Date 12/12/24
Potential Completion Date 12/13/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,129.11 firm fixed-price delivery order is for the supply of NAFTIFINE HCL 2% GEL 60GM, a topical antifungal medication. The contract has a period of performance through February 28, 2025 and is not associated with any set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,211.25 firm-fixed-price delivery order is for the supply of NAFTIN 2% GEL 45GM, a pharmaceutical product, with a completion date of January 12, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $2,009.52 and is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. The contract is for the procurement of NAFTIN 1% GEL 60GM, a pharmaceutical product, to support military...
Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract valued at $2,329.53 by the Defense Logistics Agency (DLA) to provide NAFTIN 2% GEL 45GM pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a maximum potential value of $999,999,999.00 and a period of performance...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,893.30 firm fixed-price delivery order is for the supply of Naftifine HCL 2% Cream 60GM, a topical antifungal medication. The contract has an ultimate completion date of December 27, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $12,666.29, is for the delivery of NAFTIN 1% GEL 40GM, a medical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $5,414.80 firm fixed-price delivery order is for the supply of NAFTIN 1% GEL 60GM, a pharmaceutical product. The contract has no set-aside designation and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This single-award IDC serves as the...
This federal contract award, valued at $1,080.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NAFTIN 1% GEL 60GM, a medical product, to support federal healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,125.43 Firm Fixed Price delivery order contract is for the supply of Naftifine HCL 2% Gel, a pharmaceutical product. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 27, 2024. No set-aside designation was used for this award. Amerisourcebergen holds a $999,999,999...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,738.15 firm fixed-price delivery order is for the supply of 4562275506 - NAFTIFINE HCL 1% CREAM 60GM, with an ultimate completion date of September 25, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA56D
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of NAFTIN 2% GEL 45GM, a topical antifungal medication. The $1,164.36 Firm Fixed Price Delivery Order has a ceiling value and an ultimate completion date of December 13, 2024. The contract is not designated as a set-aside.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024. These IDCs enable the company to efficiently supply a wide range of pharmaceutical products and medical supplies to support federal healthcare programs, including those serving military personnel, veterans, and other government beneficiaries.

Generated 3/13/25, 9:57 AM